Curve Inks Mammoth Deal With MSD Just Three Years After $6.1m Seed Funding

Could Receive Up To $1.7bn

 
• By Ayisha Sharma

The young UK biotech will work with MSD to discover up to five targets focused on the neurology and oncology space using its potentially ground-breaking Microcycle drug discovery technology.  

Picture of the University of Southampton building
Early Microcycle Research Was Led At The University Of Southampton • Source: Alamy

More from Deals

More from Business